Skip to content

Effects of robot-assisted gait training on gait ability in patients with Parkinson’s disease

Effects of robot-assisted gait training on gait ability in patients with Parkinson’s disease

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0006603
Enrollment
30
Registered
2021-09-27
Start date
2021-06-24
Completion date
Unknown
Last updated
2021-10-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : Control group: palliative physical therapy Treatment group: robot gait therapy Treatment time: 30 minutes/day Treatment period: 3 times a week, total of 6 weeks

Sponsors

Jeonbuk National University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Adult men and women aged between 20 and 85 2) Patients with H&Y 2 or higher diagnosed with Parkinson's disease 3) A person who fully understands the research purpose and procedure and wishes to participate in clinical research through voluntary consent

Exclusion criteria

Exclusion criteria: 1) Those with severe joint contracture 2) Those with untreated serious medical/surgical/psychiatric diseases 3) Those who weigh over 135kg or over 195cm in height 4) Pregnant women and patients who may become pregnant 5) Those with the following diseases that can be excluded according to the diagnosis and judgment of the doctor (research director) - fractures and severe arthritis - Trauma to the area where the strap is worn - A history of heart problems - History of spine surgery - Possibility of vomiting or urination - Having a serious illness 6) Those who are judged inappropriate by the researcher to participate in clinical research due to other reasons

Design outcomes

Primary

MeasureTime frame
gait distance for 2 minute;10 meter walking speed

Secondary

MeasureTime frame
Balance ability(berg balance score, Time up & go);MDS Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) part I, II, III;New Freezing of gait questionnaire; FOG-Q;levodopa-equivalent dose, LEDD, mg;(Non-Motor Symptoms Assessment Scale for Parksinson’s disease, NMSS

Countries

Korea, Republic of

Contacts

Public ContactSeung-Rok Kang

Jeonbuk National University Hospital

srkang@mdctc.or.kr+82-63-259-3458

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026